Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of Cognitive Training on Executive Functions and Decision-Making in Adolescent Female Volleyball Players

3 de julio de 2026 actualizado por: Muharrem Gökhan Beydağı, Firat University

Effects of a Short-Term Cognitive Training Programme on Executive Functions and On-Court Decision-Making Performance in Adolescent Female Volleyball Players: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of a four-week tablet-based cognitive training program on executive functions and on-court decision-making performance in adolescent female volleyball players. Fifty licensed female volleyball players aged 12 to 14 years were randomly assigned to either an intervention group or a control group. The intervention group received cognitive training three times per week in addition to routine volleyball training, while the control group continued routine training only. Executive functions were assessed using the Stroop Test, Trail Making Test-A, Go/No-Go Test, and 2-Back Test. Volleyball-specific decision-making performance was evaluated using a video-based temporal occlusion test. The study investigates whether improvements in executive functions following cognitive training transfer to sport-specific decision-making performance.

Descripción general del estudio

Descripción detallada

Executive functions, including inhibitory control, working memory, cognitive flexibility, and attentional control, play an important role in sports requiring rapid perception and decision-making, such as volleyball. Although previous studies have shown that cognitive training can improve executive functions, evidence regarding the transfer of these improvements to sport-specific performance remains inconsistent.

The purpose of this randomized controlled study is to investigate the effects of a short-term tablet-based cognitive training program on executive functions and volleyball-specific on-court decision-making performance in adolescent female volleyball players.

Fifty licensed female volleyball players aged 12 to 14 years participated in the study. Participants were randomly allocated to an intervention group or a control group. The intervention group completed a four-week cognitive training program consisting of three supervised sessions per week (20-30 minutes per session) in addition to routine volleyball training. The control group continued routine volleyball training without additional cognitive training.

Primary assessments included executive function measures obtained using the Stroop Test, Trail Making Test-A (TMT-A), Go/No-Go Test, and 2-Back Test. Volleyball-specific decision-making performance was evaluated using a video-based temporal occlusion paradigm, with decision-making accuracy and response time recorded before and after the intervention.

The study aims to determine whether short-term cognitive training improves executive function performance (near transfer) and whether these cognitive improvements translate into enhanced sport-specific decision-making performance (far transfer) in adolescent female volleyball players.

Tipo de estudio

Intervencionista

Inscripción (Actual)

50

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Female volleyball players aged 12 to 14 years.
  • Licensed volleyball players with at least 1 year of playing experience.
  • Regular participation in volleyball training during the previous 6 months.
  • Written informed consent obtained from both participants and their parents/legal guardians.

Exclusion Criteria:

  • History of neurological or psychiatric disorders.
  • Visual or hearing impairment that could affect cognitive testing.
  • Serious musculoskeletal injury within the previous 6 months.
  • Previous participation in a structured cognitive training program.
  • Injury during the study period or incomplete participation in the assessment procedures.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Cognitive Training Group
Participants received a four-week tablet-based cognitive training program (20-30 minutes/session, three sessions/week) in addition to their routine volleyball training.
A structured four-week tablet-based cognitive training program was administered three times per week for approximately 20-30 minutes per session. The program included computerized exercises targeting inhibitory control, working memory, cognitive flexibility, attention, and processing speed using validated cognitive training applications.
Participants continued their routine volleyball training according to their regular training schedule.
Comparador activo: Control Group
Participants continued their routine volleyball training without additional cognitive training.
Participants continued their routine volleyball training according to their regular training schedule.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Stroop Interference Time
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in Stroop interference time, calculated as the difference between the mean reaction time under incongruent and neutral conditions, measured in milliseconds (ms) using the computerized Stroop Color and Word Test.
Baseline and Week 4
Change in Trail Making Test-A Completion Time
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in the time required to complete the Trail Making Test-A, measured in seconds (s).
Baseline and Week 4
Change in Go/No-Go Reaction Time
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in mean reaction time during the computerized Go/No-Go Test, measured in milliseconds (ms) during correct Go responses.
Baseline and Week 4
Change in 2-Back Accuracy
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in working memory accuracy during the computerized 2-Back Test, measured as percentage of correct responses (%).
Baseline and Week 4
Change in 2-Back Reaction Time
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in mean reaction time during correct responses in the computerized 2-Back Test, measured in milliseconds (ms).
Baseline and Week 4

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in On-Court Decision-Making Accuracy
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in volleyball-specific decision-making accuracy assessed using a video-based temporal occlusion test, measured as the number of correct decisions (0-25).
Baseline and Week 4
Change in On-Court Decision-Making Response Time
Periodo de tiempo: Baseline and Week 4
Change from baseline to Week 4 in volleyball-specific decision-making response time assessed using a video-based temporal occlusion test, measured in milliseconds (ms).
Baseline and Week 4

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

2 de mayo de 2026

Finalización primaria (Actual)

15 de junio de 2026

Finalización del estudio (Actual)

15 de junio de 2026

Fechas de registro del estudio

Enviado por primera vez

29 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

3 de julio de 2026

Publicado por primera vez (Actual)

9 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

3 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • FU_MGBeydagi_Vole_B_2026/06-29

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Individual participant data (de-identified) that underlie the results reported in this study will be made available upon reasonable request to the corresponding author. Data will be available beginning 6 months after publication and ending 5 years after publication. Researchers who provide a methodologically sound proposal for achieving the aims of an approved proposal will be granted access after signing a data access agreement.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir